We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPCS:NASDAQTechPrecision Corporation Analysis

Data as of 2026-09-01 - not real-time

$5.53

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind TechPrecision Corporation is bullish at $5.53, with short-term averages leading the long-term ones. Over a rolling month the price has gained 19.4%. Momentum indicators put RSI at 56.1 (neutral) with MACD reading bearish. Recent trading has carved out support near $4.53 and resistance around $6.31.
Valuation screens as fair: a P/E of 3.5 sits below the sector average of 29.0. Revenue is growing at 23.3% on a -3.7% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 73.2%, a beta of 0.67 and a maximum drawdown of 48.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Seeking Alpha18dTechPrecision Corporation TPCS Q1 2027 Earnings Call TranscriptGreetings, and welcome to the...Nasdaq25dTechPrecision Corporation Schedules Conference Call to Report Fiscal 2027 First Quarter Financial...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 4.33
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 3.5 versus sector average of 29.0
  • Trading above the 200-day average of 4.33

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 3.5 versus sector average of 29.0
  • Negative profit margin of -3.7%
  • Negative return on equity of -15.4%

Key Metrics & Analysis

Financial Health

Revenue Growth23.30%
Profit Margin-3.66%
P/E Ratio3.5
ROE-15.42%
ROA-1.28%
Debt/Equity110.08
P/B Ratio7.2
Op. Cash Flow$1.3M
Free Cash Flow$-1076625
Industry P/E29.0

Technical Analysis

TrendBullish
RSI56.1
Support$4.53
Resistance$6.31
MA 20$5.39
MA 50$4.92
MA 200$4.33
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$2.04
GradeFair
TypeGrowth

Risk Assessment

Beta0.67
Volatility73.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.